AIDS Treatment News logo      

January 3, 2011

India rejects Abbot lab's patent application for HIV drug

The Economic Times [India]: "MUMBAI: India has rejected a drug patent application of a US multi-national pharma company, paving way for easy access to an important life-saving medication for HIV patients across the globe.

"The decision to reject the patent application on the important combination drug, Lopinavir/Ritonavir filed by Abbot Laboratories was given by the Indian patent office here during the weekend and it is a major victory to millions of HIV-positive patients around the globe, according to NGOs working with affected patients."